BACKGROUND: The confirmation of diagnosis of the Antiphospholipid Syndrome (APS)
relies on laboratory tests. Current classification criteria for definite APS mandate the use of …

There is no certainty in change, other than change is certain. As Seminars in Thrombosis
and Hemostasis celebrates 50 years of publication, I felt it appropriate to reflect on my own …

In addition to the presence of appropriate clinical features, the diagnosis of the
antiphospholipid antibody syndrome (APS) fundamentally requires the finding of positive …

Over 30 years since it was first described as a discrete clinical entity, the antiphospholipid
antibody syndrome (APS) remains a challenge for both laboratory workers and clinicians in …

Background: Anticardiolipin (aCL) and anti‐β 2 glycoprotein I (aβ 2 GPI) antibodies are part
of the criteria for antiphospholipid syndrome (APS). Therefore they are widely measured and …

INTRODUCTION: The laboratory diagnosis of antiphospholipid syndrome (APS) requires the
demonstration of antiphospholipid antibodies (aPL): lupus anticoagulant (LAC) measured …

The diagnosis of antiphospholipid syndrome is predominantly made in the laboratory and
depends on the persistent presence of antiphospholipid antibodies in individuals with …

Antiphospholipid Syndrome (APS) is a form of immune mediated thrombophilia, presenting
as recurrent thrombotic events and pregnancy morbidity, in association with positive …

Consensus guidelines on anti-cardiolipin antibody (aCL) testing have been developed to
help minimise laboratory variation in the performance and reporting of aCL assays. These …

Although much progress has been made in the past 20 years on understanding the clinical
features of antiphospholipid syndrome (APS), investigation into its epidemiology has been …